Vimarsana
Biggest News Aggregation in the World

Peter Verdult News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Peter Verdult. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Peter Verdult Today - Breaking & Trending Today

Ozempic cuts risk of death from kidney disease, major study finds - Vimarsana News

Ozempic cuts risk of death from kidney disease, major study finds

Novo Nordisk, the maker of Ozempic will seek FDA approval to dramatically expand the number of patients eligible for the shots.

Evotec SE (NASDAQ:EVO) Q1 2024 Earnings Call Transcript - Vimarsana News

Evotec SE (NASDAQ:EVO) Q1 2024 Earnings Call Transcript

Operator: Ladies and gentlemen, welcome to the Evotec SE Quarterly Statement Q1 2024 Conference Call. I am Sandra, the chorus call operator.

Grifols, S.A. (NASDAQ:GRFS) Q1 2024 Earnings Call Transcript - Vimarsana News

Grifols, S.A. (NASDAQ:GRFS) Q1 2024 Earnings Call Transcript

Daniel Segarra: Hello, everyone, and welcome to Grifols' Conference Call. Today, we will be sharing a business update on our first quarter financial results.

Novo Nordisk (NVO) Q1 2024 Earnings Call Transcript - Vimarsana News

Novo Nordisk (NVO) Q1 2024 Earnings Call Transcript

NVO earnings call for the period ending March 31, 2024.

Source: fool.com
Evotec SE (NASDAQ:EVO) Q4 2023 Earnings Call Transcript - Vimarsana News

Evotec SE (NASDAQ:EVO) Q4 2023 Earnings Call Transcript

Evotec SE misses on earnings expectations. Reported EPS is $-0.05 EPS, expectations were $-0.03333.